课题基金 / 基金详情

Development of a Novel De-Humidification Prototype System Using Evercloak's Membrane Technology

Development of a Novel De-Humidification Prototype System Using Evercloak's Membrane Technology
使用 Evercloak 膜技术开发新型除湿原型系统
批准号:
561373-2020
负责人:
Sheikhzadeh, Mehdi
金额:
$2.19万
依托单位国家:
加拿大
项目类别:
Applied Research and Development Grants - Level 1
财政年份:
2021
资助国家:
加拿大
项目状态:
已结题
起止时间:
2021-01-01 至 2022-12-31

项目摘要

项目成果

Sheikhzadeh, Mehdi的其他基金

相似基金

相关文献

中文摘要
翻译
Evercloak Inc.是一家创新的清洁技术公司,将生产连续大面积纳米薄膜涂层的制造平台商业化。他们的纳米涂层技术是一种独特的制造工艺,将氧化石墨烯材料薄层应用于商业膜支撑结构。石墨烯氧化层阻挡了所有的气体,但允许水蒸气快速通过(就像什么都没有一样)。这种材料的市场潜力包括空气过滤、天然气脱水和净化溶剂。然而,Evercloak还没有将这种膜用于特定的商业功能,以便将这项技术货币化。旨在开发一个除湿系统的原型,以测试纳米涂层技术在实际应用中的有效性。该项目将专注于开发一个快速原型系统,以评估Evercloaks(EVC)膜基催化剂技术的节能效果。此外,开发具有控制/自动化的系统,允许基于所采用的系统和环境条件进行自适应操作。Evercloak将与兰顿学院合作,根据EVC的初步试验设计、建造和测试原型加湿系统。该项目的成功将为Evercloak提供特定的仪器和控制能力,沿着一个新颖的除湿系统,使其从竞争对手中脱颖而出。预计在该成果成功商业化后的两年内,膜过滤技术的销售将起飞,这将导致潜在的170万至300万美元的销售额。随着产量的增加,预计在2-3年内将创造新的或支持现有的就业岗位,最多可提供8个全职同等职位。
英文摘要
Evercloak Inc. is an innovative cleantech company commercializing a manufacturing platform for producingcontinuous, large-area, nano-film coatings. Their nano-coating technology is a unique manufacturing process toapply a thin layer of graphene oxide material to a commercial membrane support structure. The graphene oxidelayer blocks all gas but allows water vapour to pass through quickly (as if nothing is there). The marketpotential for this material includes air dehumidification, natural gas dehydration, and purifying solvents.However, Evercloak has not adapted the membrane to a specific commercial function in order to monetize thetechnology.The proposed collaborative project with Lambton College and Evercloak Inc. aims to develop a prototype for adehumidification system that will test the effectiveness of the nano-coating technology in real-worldapplications. The project will focus on developing a rapid prototype system to assess energy savings ofEvercloaks (EVC) membrane-based dehumidification technology. Further, developing that system withcontrols/automation that will allow adaptive operation based on the system employed and the ambientconditions. Evercloak will work with Lambton College to design, build, and test the prototype humidificationsystem based on initial trails from EVC.The success of this project will provide Evercloak with specific instrumentation and control abilities along witha novel de-humidification system that will set it apart from its competitors. It is expected that the sales of themembrane dehumidification technology will take off in two years after the successful commercialization of theresults, which will lead to potentially $1.7 to $3 million in sales. With increased production, it is estimated tocreate new or supporting existing employment of up to 8 full-time equivalent positions over 2-3 years.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Optimization and Scale-Up of Graphene Oxide (GO) Ink Production Process
  • 批准号:
    CCARD-2022-00637
  • 项目类别:
    CCI Applied Research and Development Grants
  • 资助金额:
    $2.19万
  • 财政年份:
    2022
  • 负责人:
    Sheikhzadeh, Mehdi
  • 依托单位:
Lambton Circular Economy Innovation Platform (LCEIP)
Regeneration of Phosphorous Saturated Activated Alumina
  • 批准号:
    CCARD-2022-00214
  • 项目类别:
    CCI Applied Research and Development Grants
  • 资助金额:
    $1.82万
  • 财政年份:
    2022
  • 负责人:
    Sheikhzadeh, Mehdi
  • 依托单位:
Canadian Materials Circular Economy Syndicate (CMCES)
  • 批准号:
    CCB21-2021-00265
  • 项目类别:
    Applied Research and Technology Partnership Grants
  • 资助金额:
    $45.25万
  • 财政年份:
    2022
  • 负责人:
    Sheikhzadeh, Mehdi
  • 依托单位:
国内基金
海外基金
Novel-miR-1134调控LHCGR的表达介导拟 穴青蟹卵巢发育的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2025
  • 负责人:
    崔文晓
  • 依托单位:
novel-miR75靶向OPR2,CA2和STK基因调控人参真菌胁迫响应的分子机制研究
  • 批准号:
    82304677
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30.00万元
  • 批准年份:
    2023
  • 负责人:
    边兴博
  • 依托单位:
海南广藿香Novel17-GSO1响应p-HBA调控连作障碍的分子机制
  • 批准号:
    82304658
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2023
  • 负责人:
    刘亚
  • 依托单位:
白术多糖通过novel-mir2双靶向TRADD/MLKL缓解免疫抑制雏鹅的胸腺程序性坏死
  • 批准号:
    32102747
  • 项目类别:
    青年科学基金项目(C类)
  • 资助金额:
    30.0万元
  • 批准年份:
    2021
  • 负责人:
    李婉雁
  • 依托单位: